SCHEMBL9975647

SCHEMBL9975647

CCC1(C)CCN(c2ccccc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 3/20 0.53
SIGMAR1 Q99720 2/20 0.50
DRD2 P14416 1/20 0.50
USP2 O75604 3/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 2/20 0.47
CYP3A4 P08684 3/20 0.46
MAPK1 P28482 2/20 0.46
ALOX15 P16050 1/20 0.46
CHRNB2 P17787 1/20 0.46
NFKB1 P19838 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRNA4 P43681 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ALDH1A1 P00352 2/20 0.44
CYP1A2 P05177 2/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
POLB P06746 1/20 0.44
APOBEC3A P31941 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9975643 0.89 CHRNA7 (0.46) CHRNA7SIGMAR1DRD2USP2CYP2D6
SCHEMBL28697423 0.83 USP2 (0.50) CHRNA7SIGMAR1DRD2USP2CYP2D6
SCHEMBL26407337 0.82 CHRNA7 (0.55) CHRNA7SIGMAR1DRD2USP2CYP2D6
SCHEMBL23555238 0.81 CHRNA7 (0.46) CHRNA7SIGMAR1DRD2USP2CYP2D6
SCHEMBL2946610 0.80 USP2 (0.54) CHRNA7USP2CYP2C9MAPK1ALOX15
SCHEMBL1107775 0.79 USP2 (0.55) CHRNA7SIGMAR1DRD2USP2CYP2D6
Ammonia Solution, Strong SCHEMBL28324490 0.78 USP2 (0.53) CHRNA7SIGMAR1DRD2USP2CYP2D6
SCHEMBL22657654 0.76 USP2 (0.52) CHRNA7SIGMAR1DRD2USP2CYP2D6
SCHEMBL28471992 0.76 USP2 (0.54) CHRNA7SIGMAR1DRD2USP2CYP2D6
SCHEMBL26834764 0.76 USP2 (0.52) CHRNA7SIGMAR1DRD2USP2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11832508-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2023-11-28 US disclosed
US-10403832-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2019-09-03 US disclosed
US-8945725-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2015-02-03 US disclosed
US-20120153816-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11832508-B2 Organic electroluminescence device LAGE3, L1CAM, LEF1 CHRNA7 652/4885SIGMAR1 3503/4885DRD2 2332/4885
US-20120153816-A1 ORGANIC ELECTROLUMINESCENCE DEVICE L1CAM, LAGE3, LEF1 CHRNA7 870/4885SIGMAR1 3166/4885DRD2 2594/4885
US-10403832-B2 Organic electroluminescence device LAGE3, L1CAM, LEF1 CHRNA7 687/4885SIGMAR1 3453/4885DRD2 2362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.